Better patient outcomes and health economics with ZedScan
Tuesday 3rd November 2015
Clinicians at a UK NHS clinic have been using ZedScan alongside colposcopy over a period of 18 months assessing the impact on the patient pathway for women referred with abnormal cytology.
Performance data on 1,052 women examined revealed a 12.4% increase in the detection of high grade cervical intraepithelial neoplasia (HG CIN) following the introduction of ZedScan into routine use.
There was also a marked increase (57.4%) in the number of cases of high grade disease detected in women referred with mild or borderline abnormalities.
Benefits in patient management were also evident with treatment at first visit (‘See and Treat’) rate since ZedScan has been introduced has increased from 36-39% in previous years to 61% of all high grade referrals; high grade disease was confirmed in 97.7% of the cases.
The report concludes that adoption of ZedScan has created opportunities for more efficient use of resources by offering treatment at first visit as well as providing the reassurance to release women without disease to routine surveillance and reducing the need for further follow up.
ZedScan has been approved for use in a number of international markets including Canada, Australia, Bahrain and Israel, as well as a number of European countries.
Sameer Kothari, Chief Executive of Zilico Limited, said: “ZedScan is currently being integrated in to routine clinical practice by a number of international healthcare providers.
“With the latest clinical data, ongoing international adoption of ZedScan and continued interest from key opinion leaders and influential clinicians from the field, we now look forward to satisfying the growing demand with new potential partners at the world’s biggest healthcare exhibition.”
MEDICA will take place between the 16 – 19 November 2015 at the Messe Düsseldorf, Germany. Zilico Ltd will be located at Hall 16 Stand G18-7.
If you would like to arrange an appointment with Zilico Ltd to discuss ZedScan during MEDICA, please email Catherine.firstname.lastname@example.org with your details and some information about your company.
If you would like to arrange a media interview with Zilico Ltd before or during Medica, please contact:
Martin Webb, PR Consultant at Propeller PR:
Tel: +44 (0)7766410194
Email : email@example.com